Rite Aid Corp (RAD)
2.22
-0.15
(-6.33%)
USD |
NYSE |
Mar 23, 16:00
2.25
+0.03
(+1.35%)
After-Hours: 20:00
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 125.48M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | -77.02% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 0.0050 |
| Price to Book Value | -- |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | -7.914 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 97.22% |
News
Headline
Wire
Time (ET)
PR Newswire
03/22 17:55
Globe Newswire
03/21 19:31
Globe Newswire
03/21 18:24
Globe Newswire
03/21 13:28
Globe Newswire
03/16 11:50
PR Newswire
03/15 20:25
Yahoo
03/14 18:40
Events
| DATE | TIME | TYPE | PERIOD | REPORTED EPS |
ESTIMATED EPS |
SURPRISE | |
| 04/14/2023* | 08:30 EST | Earnings Call | Q4 2023 | -- | -- | -- | |
| 04/14/2023* | -- | Results | Q4 2023 | -- | -0.77 | -- | |
| 12/21/2022 | 08:30 EST | Earnings Call | Q3 2023 | -- | -- | -- | |
| 12/21/2022 | -- | Results | Q3 2023 | -0.14 | -0.31 | 55.49% | |
| 09/29/2022 | 08:30 EST | Earnings Call | Q2 2023 | -- | -- | -- | |
| 09/29/2022 | -- | Results | Q2 2023 | -0.63 | -0.55 | -13.87% | |
| 06/23/2022 | 08:30 EST | Earnings Call | Q1 2023 | -- | -- | -- | |
| 06/23/2022 | -- | Results | Q1 2023 | -0.60 | -0.70 | 14.31% |
*Estimated Date/Time
Earnings
Profile
Edit
| Rite Aid Corp is a large retail drugstore chain in the United States. The company reports via two segments: retail pharmacy and pharmacy services. The retail pharmacy segment generates revenue primarily through the sale of prescription drugs, along with an assortment of merchandise that includes over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and numerous other everyday consumables. The pharmacy-services segment relates to EnvisionRx, a fully owned subsidiary that operates as a pharmacy benefit management provider offering a broad range of pharmaceutical services. |
| URL | https://www.riteaid.com |
| Investor Relations URL | https://investors.riteaid.com/ |
| HQ State/Province | Pennsylvania |
| Sector | Healthcare |
| Industry | Pharmaceutical Retailers |
| Equity Style | Small Cap/Value |
| Next Earnings Release | Apr. 14, 2023 (est.) |
| Last Earnings Release | Dec. 21, 2022 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Oct. 14, 1999 |
Analyst Coverage
|
Consensus Rating
|
|
|
Analyst Recommendation
|
|
Source: S&P Global
Dividends
| Dividend Per Share (TTM) | 0.00 |
|
2017
2018
2019
2020
2021
6.00%
4.00%
2.00%
|
|
| Yield to Market | 0.00 |
| Yield to Sector | 0.00 |
| Yield to Industry | 0.00 |
| Last Dividend Amt. | -- |
| Dividend Frequency | -- |
| Last Ex-Dividend Date | Oct. 14, 1999 |
| Yield (TTM) | 0.00% |
| Forward Yield | -- |
| Payout Ratio | 0.00% |
| Cash Payout Ratio | 0.00% |
| Consistent Payer (5Y) | No |
| Consistent Growth (5Y) | No |
Risk
Total Returns Comparison
Annual Total Returns Versus Peers
As of March 23, 2023.
Fundamentals
| Revenue (TTM) | 24.06B |
| Total Expenses (TTM) | 24.12B |
| Net Income (TTM) | -897.69M |
| Total Assets (Quarterly) | 8.210B |
| Total Liabilities (Quarterly) | 8.614B |
| Shareholders Equity (Quarterly) | -403.73M |
| Cash from Operations (TTM) | 23.86M |
| Cash from Investing (TTM) | -113.41M |
| Cash from Financing (TTM) | 37.31M |
Ratings
Profile
Edit
| Rite Aid Corp is a large retail drugstore chain in the United States. The company reports via two segments: retail pharmacy and pharmacy services. The retail pharmacy segment generates revenue primarily through the sale of prescription drugs, along with an assortment of merchandise that includes over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and numerous other everyday consumables. The pharmacy-services segment relates to EnvisionRx, a fully owned subsidiary that operates as a pharmacy benefit management provider offering a broad range of pharmaceutical services. |
| URL | https://www.riteaid.com |
| Investor Relations URL | https://investors.riteaid.com/ |
| HQ State/Province | Pennsylvania |
| Sector | Healthcare |
| Industry | Pharmaceutical Retailers |
| Equity Style | Small Cap/Value |
| Next Earnings Release | Apr. 14, 2023 (est.) |
| Last Earnings Release | Dec. 21, 2022 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Oct. 14, 1999 |
Ownership
| Insider Ownership Percentage | Upgrade |
Jul '20
Nov '20
Mar '21
80.00%
40.00%
10.00%
Analyst Coverage
|
Consensus Rating
|
|
|
Analyst Recommendation
|
|
Source: S&P Global
Other Resources
| Whale Wisdom | 13F Filings |
| Seeking Alpha | Call Transcripts |
| Nasdaq | Insider Trading |
| Nasdaq | Institutional Ownership |
| Nasdaq | Option Chain |
| SEC | SEC Filings |
| RAD Tweets |